MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 81 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $118,000 | +110.7% | 46,734 | +71.0% | 0.00% | – |
| Q1 2020 | $56,000 | -49.5% | 27,329 | -46.9% | 0.00% | – |
| Q4 2019 | $111,000 | +22.0% | 51,468 | -12.8% | 0.00% | – |
| Q3 2019 | $91,000 | -32.1% | 59,031 | +82.5% | 0.00% | – |
| Q2 2019 | $134,000 | +139.3% | 32,351 | +142.6% | 0.00% | – |
| Q1 2019 | $56,000 | -1.8% | 13,336 | -33.3% | 0.00% | – |
| Q4 2018 | $57,000 | -90.3% | 20,000 | -65.8% | 0.00% | – |
| Q3 2018 | $585,000 | +75.7% | 58,556 | +24.4% | 0.00% | – |
| Q2 2018 | $333,000 | +43.5% | 47,057 | -22.2% | 0.00% | – |
| Q1 2018 | $232,000 | – | 60,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,340,588 | $1,354,000 | 0.34% |
| BOOTHBAY FUND MANAGEMENT, LLC | 78,662 | $79,000 | 0.02% |
| Orbimed Advisors | 567,600 | $573,000 | 0.01% |
| Acrospire Investment Management LLC | 14,323 | $14,000 | 0.01% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 10,000 | $10,000 | 0.00% |
| Virtu KCG Holdings LLC | 49,847 | $50,000 | 0.00% |
| NEXT Financial Group, Inc | 2,670 | $3,000,000 | 0.00% |
| Squarepoint Ops LLC | 13,000 | $13,000 | 0.00% |
| FRANKLIN RESOURCES INC | 2,182,185 | $2,204,000 | 0.00% |
| A.R.T. Advisors, LLC | 16,830 | $16,000 | 0.00% |